alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### IVAN McLAUGHLIN and TIMOTHY STANLEY v. DANIEL BAILEY, in his individual and official capacity as Sheriff of Mecklenburg County, and OHIO CASUALTY INSURANCE COMPANY

No. 163A15

Filed 29 January 2016

Appeal pursuant to N.C.G.S. § 7A-30(2) from the decision of a divided panel of the Court of Appeals,_N.C. App._, 771 S.E.2d 570 (2015), affirming an order granting summary judgment entered on 6 January 2014 by Judge Robert C. Ervin in Superior Court, Mecklenburg County. On 20 August 2015, the Supreme Court allowed plaintiffs’ petition for discretionary review of additional issues. Heard in the Supreme Court on 7 December 2015.

*Kennedy, Kennedy, Kennedy and Kennedy, LLP, by Harold L. Kennedy, III and Harvey L. Kennedy, for plaintiff-appellants.*

*Womble, Carlyle, Sandridge and Rice, LLP, by Sean F. Perrin, for defendant-appellees.*

*Tin Fulton Walker & Owen, PLLC, by William G. Simpson, Jr.; and Pinto Coates Kyre & Bowers, PLLC, by Jon Ward, for North Carolina Advocates for Justice, amicus curiae.*

*Edmond W. Caldwell, Jr., General Counsel, North Carolina Sheriffs’ Association, amicus curiae.*

*Bailey & Dixon, LLP, by Jeffrey P. Gray; and McGuinnéss Law Firm, by J. Michael McGuinness, for North Carolina State Lodge of the Fraternal Order of Police, amicus curiae.*

PER CURIAM.

For the reasons stated in *Young v.*Bailey, _ N.C. _, _ S.E.2d _ (2016) (355PA14-2), plaintiffs’ suit under N.C.G.S. § 153A-99 fails. In addition, the suit brought by plaintiff Stanley pursuant to the North Carolina Constitution and the United States Constitution fails for the reasons set out in *Young v. Bailey.*

Unlike plaintiff Stanley, however, plaintiff McLaughlin was not a sworn law enforcement officer, and thus *Young v. Bailey*does *619not dispose of McLaughlin’s constitutional claims. We need not address whether a non-deputy employee of a sheriff, like McLaughlin, may be legally fired on the basis of political speech. Instead, the record indicates that plaintiff McLaughlin violated the department’s policies by failing to properly conduct his pod tours and by falsifying paperwork submitted to his supervisors. The record also shows that plaintiff conceded to such allegations and that his termination was upheld by a department review board.

Based on this record, and applying de novo review, *Robins v. Town of Hillsborough,*361 N.C. 193, 196, 639 S.E.2d 421, 423 (2007), we conclude that the trial court properly granted defendants’ motion for summary judgment. Even if defendant Bailey knew that plaintiff McLaughlin did not contribute to his reelection campaign, defendant Bailey had sufficient job-related reasons to terminate this plaintiff. Accordingly, plaintiff McLaughlin’s constitutional claims also fail. *See Anderson v. Assimos,*356 N.C. 415, 416, 572 S.E.2d 101, 102 (2002) (per curiam) (“[T]he courts of this State will avoid constitutional questions, even if properly presented, where a case may be resolved on other grounds.”).

AFFIRMED.

Justice ERVIN did not participate in the consideration or decision of this case.
#### § 109-39.301 Utilization guidelines.

DOE activities utilizing GSA IFMS motor vehicles will receive and review vehicle utilization statistics in order to determine if miles traveled justify vehicle inventory levels. Activities should retain justification for the retention of vehicles not meeting DOE utilization guidelines or established local use objectives, as appropriate. Those vehicles not justified for retention shall be returned to the issuing GSA interagency fleet management center.
§ 105-72.201 Pre-award policies. ( a ) *Use of grants and cooperative agreements, and contracts.* In each instance, the Federal awarding agency shall decide on the appropriate award instrument (i.e., grant, cooperative agreement, or contract). The Federal Grant and Cooperative Agreement Act (31 U.S.C. 6301-08) governs the use of grants, cooperative agreements and contracts. A grant or cooperative agreement shall be used only when the principal purpose of a transaction is to accomplish a public purpose of support or stimulation authorized by Federal statute. The statutory criterion for choosing between grants and cooperative agreements is that for the latter, “substantial involvement is expected between the executive agency and the State, local government, or other recipient when carrying out the activity contemplated in the agreement.” Contracts shall be used when the principal purpose is acquisition of property or services for the direct benefit or use of the Federal Government.
( b ) *Public notice and priority setting.* Federal awarding agencies shall notify the public of its intended funding priorities for discretionary grant programs, unless funding priorities are established by Federal statute.
135 San Lorenzo Avenue, Suite 770, Coral Gables, Florida 33146

TEL 305.230.4884 FAX 305.230.4844

www.fairlawattorney.com

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF FLORIDA

CASE NO.: 1:22-CV-23074-BLOOM/OTAZO-REYES

OCTAVIO COLLADO,

Plaintiff, COLLECTIVE ACTION 

vs.

450 NORTH RIVER DRIVE, LLC,

D/B/A KIKI ON THE RIVER, 

RJ RIVER, LLC AND 

ROMAN JONES,

Defendants.

______________________________/

PLAINTIFF’S NOTICE OF FILING CONSENT TO JOIN 

(Karim Elghannam) 

 

Plaintiff, Octavio Collado, notices the Court and all parties of the filing of the Consent to 

Join in these proceedings by Karim Elghannam.

Dated this 24th day of August 2023. 

s/Brian H. Pollock, Esq.

Brian H. Pollock, Esq.

Fla. Bar No. 174742

brian@fairlawattorney.com

FAIRLAW FIRM

135 San Lorenzo Avenue

Suite 770

Coral Gables, FL 33146

Tel: 305.230.4884

Counsel for Plaintiff(s)

Case 1:22-cv-23074-BB Document 196 Entered on FLSD Docket 08/24/2023 Page 1 of 1
<PAGE>

                                                                   EXHIBIT 32.1


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Allis-Chalmers
Corporation. (the "Company") for the period ended September 30, 2004, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of the operations of the Company.



DATE: MARCH 7, 2005                          BY:  /S/ MUNAWAR H. HIDAYATALLAH
                                                  ---------------------------
                                                  MUNAWAR H. HIDAYATALLAH
                                                  CHIEF EXECUTIVE OFFICER


DATE: MARCH 7, 2005                          BY:  /S/ TODD C. SEWARD
                                                  ---------------------------
                                                  TODD C. SEWARD
                                                  CHIEF ACCOUNTING OFFICER
§ 102-34.40 Who must comply with motor vehicle fuel efficiency requirements? ( a ) Executive agencies operating domestic fleets must comply with motor vehicle fuel efficiency requirements for such fleets.
( b ) This subpart does not apply to motor vehicles exempted by law or other regulations, such as law enforcement or emergency rescue work and foreign fleets. Other Federal agencies are encouraged to comply so that maximum energy conservation benefits may be realized in obtaining, operating, and managing Government motor vehicles.
No. 11-9332.

#### Qualls v. United States.

C. A. 4th Cir. Cer-tiorari denied.
**Exhibit 32.1**

 

**CERTIFICATIONPURSUANT TO**

**SECTION 1350,CHAPTER 63 OF TITLE 18, UNITED STATES CODE**

 

**AS ADOPTEDPURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

 

Pursuant to Section 1350, Chapter 63 of Title 18, United StatesCode, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, the undersigned, the President and Chief Executive Officer of AmericanScience & Engineering, Inc. (the “Company”), does hereby certifythat to the undersigned’s knowledge:

 

1.                  theCompany’s Report on Form 10-Q for the quarter ended June 30, 2005(“10-Q”) fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

2.                  theinformation contained in the Company’s 10-Q being filed fairly presents, in allmaterial respects, the financial condition and results of operation of theCompany.

 

 
| Date: August 9, 2005 | /s/Anthony R. Fabiano                                     |   |
|---------------------------|-----------------------------------------------------------|--------|
|                      | Anthony R. Fabiano  President and Chief Executive Officer |

 

 

A signed original of this written statement required by Section 906has been provided to American Science & Engineering, Inc. andwill be retained by American Science & Engineering, Inc. andfurnished to the Securities and Exchange Commission or its staff upon request.

 

1

----
#### § 102-74.440 What is the policy concerning weapons on Federal property?

Federal law prohibits the possession of firearms or other dangerous weapons in Federal facilities and Federal court facilities by all persons not specifically authorized by 18 U.S.C. 930. Violators will be subject to fine and/or imprisonment for periods up to five (5) years.
EXHIBIT 31.a

I, John P. Manning, certify that:

1. I have reviewed this annual report on Form 10-K of BCTC IV Assignor Corp. (the "Assignor");
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Assignor as of, and for, the periods presented in this report;
4. The Assignor's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Assignor and have:



1. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the Assignor, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. evaluated the effectiveness of the Assignor's disclosure controls and procedures  and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



1. The Assignor's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Assignor's auditors and the audit committee of the Assignor's board of directors (or persons performing the equivalent functions):



1. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Assignor's ability to record, process, summarize and report financial information; and
2. any fraud, whether or not material, that involves management or other employees who have a significant role in the Assignor's internal control over financial reporting.



|Date:  March 31, 2006 | /s/ John P. Manning 
|--------------------- | --------------------
|                      | John P. Manning     
|                      | Director, President 
|                      | (Principal Executive
|                      | Officer), BCTC IV   
|                      | Assignor Corp.
123A13

#### Vincent Burley, Employee v. U.S. Foods, Inc., Employer, and Indemnity Insurance Company of North America, Carrier (with Gallagher Bassett Services, Inc., Third-Party Administrator)

Pit’s Petition for Rehearing Under N.C. R. App. 31

Denied 11/12/2015
106TH CONGRESS

1ST SESSION H. R. 808

AN ACT

To extend for 6 additional months the period for

is reenacted.which chapter 12 of title 11, United States Code,
106TH CONGRESS

1ST SESSION H. R. 808

AN ACT

To extend for 6 additional months the period for which

chapter 12 of title 11, United States Code, is reenacted.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 808 EH

1 SECTION 1. AMENDMENTS.

2 Section 149 of title I of division C of Public Law

3 105–277 is amended—

4 (1) by striking ‘‘April 1, 1999’’ each place it

5 appears and inserting ‘‘October 1, 1999’’;

6 (2) in subsection (a)—

7 (A) by striking ‘‘September 30, 1998’’ and

8 inserting ‘‘March 31, 1999’’; and

9 (B) by striking ‘‘October 1, 1998’’ and in10 serting ‘‘April 1, 1999’’; and

11 (3) by striking subsection (c).

12 SEC. 2. EFFECTIVE DATE.

13 The amendments made by section 1 shall take effect

14 on April 1, 1999.

Passed the House of Representatives March 11,

1999.

Attest:

Clerk.
1

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 17-1556V

Filed: April 7, 2021

* * * * * * * * * * * * *

ROBIN COOLEY, * UNPUBLISHED

*

Petitioner, * Decision on Joint Stipulation;

* Shoulder Injury Related to

v. * Vaccine Administration

* (“SIRVA”); Influenza (“Flu”)

SECRETARY OF HEALTH * Vaccine.

AND HUMAN SERVICES, *

*

Respondent. *

* * * * * * * * * * * * *

Mari Bush Esq., Mari C. Bush LLC, Boulder, CO, for petitioner.

Adriana Teitel, Esq., US Department of Justice, Washington, DC, for respondent.

DECISION ON JOINT STIPULATION1

Roth, Special Master:

On October 18, 2017, Robin Cooley [“Ms. Cooley” or “petitioner”] filed a petition for 

compensation under the National Vaccine Injury Compensation Program.

2 Petitioner alleges that 

she suffered a shoulder injury related to vaccine administration (“SIRVA”) after receiving an 

influenza (“flu”) vaccine on December 13, 2016. Stipulation, filed April 7, 2021, at ¶¶ 1-4. 

Respondent denies that the immunization caused petitioner’s injury. Stipulation at ¶ 6.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the 

Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 

116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will 

be available to anyone with access to the internet. However, the parties may object to the Decision’s 

inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party 

has fourteen days within which to request redaction “of any information furnished by that party: (1) that is 

a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes 

medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of 

privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease 

of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa 

(2012).
2

Nevertheless, the parties have agreed to settle the case. On April 7, 2021, the parties filed 

a joint stipulation agreeing to settle this case and describing the settlement terms.

 

Respondent agrees to issue the following payment:

A lump sum of $27,500.00 in the form of a check payable to petitioner, Robin 

Cooley. This amount represents compensation for all damages that would be available 

under § 300aa-15(a).

I adopt the parties’ stipulation attached hereto, and award compensation in the amount and 

on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance 

with this decision.3

IT IS SO ORDERED.

s/ Mindy Michaels Roth

 Mindy Michaels Roth

 Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice 

renouncing the right to seek review.
§ 102-75.942 What must agencies consider when granting easements? Agencies must— ( a ) Determine the easement's fair market value; and
( b ) Determine the remaining property's reduced or enhanced value because of the easement.
Natoma

Manors

Bay

Heights

Golden Pines

North

Grove

Shorecrest

Bay Point

Miami International Airport

Morningside

Grapeland Heights

Little Havana Dodge Island

Shenandoah

Virginia Key

Auburndale

Liberty City

Silver Bluff

Wynwood

Little River

Downtown

The Roads

Allapattah

Little Haiti

Overtown

Flagami

Brickell

Omni

C

O

C

O

N

U

T

G

R

O

V

E

pU

ep Er sa St edi

r et a wegdE

V

e

r

sio

n

1

2

D

e

G

r

a

n

dy’s

D

r

aft

P

l

a

n

P

r

op

o

s

a

l

Districts

12345

Case 1:22-cv-24066-KMM Document 173-16 Entered on FLSD Docket 02/02/2024 Page 1 of 1
EX-4.1



 Exhibit 4.1 

SEE REVERSE SIDE FOR RESTRICTIVE LEGEND(S) 
  

			
	 NUMBER

PE-        
	 	
*                    *
SHARES
 SERIES E CONVERTIBLE PREFERRED STOCK


 CASCADIAN THERAPEUTICS, INC. 

INCORPORATED UNDER THE LAWS 
 OF
THE STATE OF DELAWARE 
 This Certifies That
                                        
 is the record holder of
                                        
 (                    ) fully paid and nonassessable shares of Series E Convertible Preferred Stock of CASCADIAN THERAPEUTICS,
INC., transferable only on the books of the said Corporation by the holder hereof in person or by a duly authorized attorney upon surrender of this certificate properly endorsed or assigned. 

This certificate and the shares it represents are subject to the provisions of the Certificate of Incorporation, the Certificate of Designation of
Preferences, Rights and Limitations of Series E Convertible Preferred Stock and the Bylaws of the corporation, and any amendments thereto, as well as the restrictive legends on the back of this certificate. Upon request, stockholders may obtain free
of charge from the corporation’s principal office a statement describing the preferences, limitations and relative rights granted to or imposed upon each class or series of shares or upon the holders of such shares. 

IN WITNESS WHEREOF, the said Corporation has caused this certificate to be signed by its duly authorized officers this
     day of January, 2017. 
  

					
			
	   
	 		 	   

	 Scott Myers
 President and Chief Executive
Officer
	 		 	 Julie M. Eastland
 Secretary









 FOR VALUE RECEIVED, THE UNDERSIGNED HEREBY SELLS, ASSIGNS AND TRANSFERS UNTO
                                        ,
                                        
 SHARES REPRESENTED BY THIS CERTIFICATE AND DOES HEREBY IRREVOCABLY CONSTITUTE AND APPOINT
                                        
 ATTORNEY TO TRANSFER SAID SHARES ON THE SHARE REGISTER OF THE CORPORATION WITH FULL POWER OF SUBSTITUTION IN THE PREMISES. 
  

					
	 DATED
	 	  
	  	
		 		  	  

		 		  	(Signature)

 NOTICE: The signature on this assignment must correspond with the name as written upon the face of this certificate, in every
particular, without alteration or enlargement, or any change whatsoever
#### § 109-38.201 Registration and inspection.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED CONDENSED FINANCIAL STATEMENTS OF AMERICAN SCIENCE AND
ENGINEERING, INC. FOR THE THREE MONTHS ENDED JUNE 30, 1998 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               JUN-30-1998
<EXCHANGE-RATE>                                      1
<CASH>                                           1,401
<SECURITIES>                                         0
<RECEIVABLES>                                    7,760
<ALLOWANCES>                                         0
<INVENTORY>                                      9,396
<CURRENT-ASSETS>                                26,370
<PP&E>                                           2,218
<DEPRECIATION>                                   9,578
<TOTAL-ASSETS>                                  28,809
<CURRENT-LIABILITIES>                           11,254
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,181
<OTHER-SE>                                      13,679
<TOTAL-LIABILITY-AND-EQUITY>                    28,809
<SALES>                                         11,692
<TOTAL-REVENUES>                                11,692
<CGS>                                            7,239
<TOTAL-COSTS>                                   10,778
<OTHER-EXPENSES>                                    38
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    876
<INCOME-TAX>                                       350
<INCOME-CONTINUING>                                526
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       526
<EPS-PRIMARY>                                     0.13
<EPS-DILUTED>                                     0.10
        

</TABLE>